S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Inflation Tips for Startups – Top 11
The Next Big Crisis Is Here (Ad)
Trustees picked by DeSantis may change progressive college
Qatar replaces Russian company in Lebanon gas exploration
The Next Big Crisis Is Here (Ad)
France must raise pension age to 64, prime minister says
Elon Musk's mysterious ways on display in Tesla tweet trial
The Next Big Crisis Is Here (Ad)
Biden, McCarthy to discuss debt limit in talks on Wednesday
Dutch firm: US, allies near deal to limit chip tech to China
NASDAQ:ATRA

Atara Biotherapeutics - ATRA SEC Filings & 10K Form

$5.27
+0.33 (+6.68%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$4.93
$5.30
50-Day Range
$2.85
$5.27
52-Week Range
$2.83
$16.07
Volume
785,993 shs
Average Volume
1.05 million shs
Market Capitalization
$500.02 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$21.63

Recent Atara Biotherapeutics SEC Filings

DateFilerForm TypeView
01/06/2023
3:16 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/20/2022
3:42 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2022
7:05 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2022
4:43 PM
Atara Biotherapeutics (Issuer)
Banard Charlene A. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/18/2022
7:13 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2022
7:13 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2022
7:13 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2022
7:13 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2022
3:20 PM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/28/2022
3:30 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/27/2022
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/18/2022
5:20 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
5:21 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
5:21 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/18/2022
5:24 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2022
3:14 PM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/22/2022
3:06 PM
Atara Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
06/29/2022
3:48 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
MALLIK AMEET (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/27/2022
3:48 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2022
3:02 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/19/2022
4:16 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
4:20 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
4:04 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2022
4:08 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2022
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/19/2021
6:32 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
6:34 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
6:35 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
6:36 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2021
6:37 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2021
3:02 PM
Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:09 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:11 PM
Atara Biotherapeutics (Issuer)
Roncarolo Maria Grazia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:13 PM
Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:14 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:16 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:03 PM
Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:05 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
6:07 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2021
3:06 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:29 PM
Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:30 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:31 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:32 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:32 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2021
3:33 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/17/2021
5:32 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2021
3:36 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
4:18 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/30/2021
4:19 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2021
6:25 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:13 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:14 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:15 PM
Atara Biotherapeutics (Issuer)
Yarema Kristin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:15 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:16 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2021
4:17 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/01/2021
4:05 PM
Atara Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/09/2021
6:59 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/09/2021
6:59 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2021
3:02 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2021
6:31 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2020
5:35 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2020
4:08 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2020
7:26 AM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2020
3:07 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:07 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/18/2020
3:08 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/16/2020
3:19 PM
Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2020
3:41 PM
Atara Biotherapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/09/2020
3:11 PM
Atara Biotherapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/09/2020
3:05 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/20/2020
6:37 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
6:38 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2020
6:39 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2020
3:18 PM
Atara Biotherapeutics (Issuer)
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
8:15 PM
Atara Biotherapeutics (Issuer)
SEIDENBERG BETH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:43 PM
Atara Biotherapeutics (Issuer)
Baynes Roy D. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:44 PM
Atara Biotherapeutics (Issuer)
DOBMEIER ERIC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:45 PM
Atara Biotherapeutics (Issuer)
Fust Matthew K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:46 PM
Atara Biotherapeutics (Issuer)
Gallagher Carol Giltner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2020
4:46 PM
Atara Biotherapeutics (Issuer)
HEIDEN WILLIAM K (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:10 PM
Atara Biotherapeutics (Issuer)
Touchon Pascal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:11 PM
Atara Biotherapeutics (Issuer)
Koppikar Utpal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2020
5:11 PM
Atara Biotherapeutics (Issuer)
Newell Joe (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2020
6:16 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/19/2020
6:17 PM
Atara Biotherapeutics (Issuer)
Dupont Jakob (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
6:43 PM
Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/30/2020
6:44 PM
Atara Biotherapeutics (Issuer)
Renaud Ronald C JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
4:25 PM
Atara Biotherapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/21/2020
3:16 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/21/2020
3:17 PM
Atara Biotherapeutics (Issuer)
Murugan Amar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page (NASDAQ:ATRA) was last updated on 1/29/2023 by MarketBeat.com Staff